Cefixime tablets make return to market
Lupin Pharmaceuticals announces manufacture of cefixime 400-mg tablets.
Since 2002, when Lupin Pharmceuticals. Now Lupin has announced they will start making the antibiotic in a 400-mg tablet. Cefixime is the only oral agent currently recommended by the Centers for Disease Control & Prevention for the treatment of uncomplicated urogenital or rectal gonnorhea.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Recent Videos
Related Content
Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear
Brian Nowosielski;Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP;Ashley Gallagher
January 7th 2025Article
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.
